Farallon Capital Management, L.L.C. / TMO
Farallon Capital Management, L.L.C.’s Thermo Fisher Scientific Inc Position
Does Farallon Capital Management, L.L.C. own Thermo Fisher Scientific Inc (TMO)? Yes — 881.5K shares worth $433M (+2.35% of its 13F portfolio) as of Q1 2026, up from 635.7K shares the prior filed quarter.
Position Value
$433M
Q1 2026
Shares
881.5K
% of Portfolio
+2.35%
Quarters Held
26
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 881.5K | $433M | +2.35% |
| Q4 2025 | 635.7K | $368M | +1.74% |
| Q3 2025 | 1.26M | $610M | +2.50% |
| Q2 2025 | 1.38M | $561M | +2.36% |
| Q1 2025 | 1.04M | $515M | +2.76% |
| Q4 2024 | 1.23M | $642M | +3.25% |
| Q3 2024 | 709.5K | $439M | +2.13% |
| Q2 2024 | 739.2K | $409M | +1.92% |
| Q1 2024 | 797.4K | $463M | +2.10% |
| Q4 2023 | 1.20M | $639M | +2.79% |
| Q3 2023 | 1.05M | $530M | +2.28% |
| Q2 2023 | 1.24M | $649M | +3.62% |
| Q1 2023 | 1.05M | $605M | +2.98% |
| Q4 2022 | 1.16M | $640M | +4.19% |
| Q3 2022 | 1.12M | $569M | +3.13% |
| Q2 2022 | 1.24M | $675M | +3.81% |
| Q1 2022 | 1.22M | $723M | +3.18% |
| Q4 2021 | 973.0K | $649M | +3.37% |
| Q3 2021 | 979.7K | $560M | +2.70% |
| Q2 2021 | 1.34M | $678M | +2.79% |
| Q1 2021 | 1.16M | $527M | +2.92% |
| Q4 2020 | 1.11M | $519M | +3.32% |
| Q3 2020 | 1.10M | $484M | +3.38% |
| Q2 2020 | 1.07M | $388M | +3.14% |
| Q1 2020 | 1.24M | $353M | +2.17% |
| Q4 2019 | 853.2K | $277M | +2.22% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of TMO.